Q32 Bio Inc
QTTB
NASDAQ
Biotechnology
$15.15
USD
-0.22 (-1.43%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $468.57M
Volume 311.8K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
MPLT | MapLight Therapeutics Inc | $519.09M | - | - | - | |
KYTX | Kyverna Therapeutics Inc | $479.67M | - | - | - | |
QTTB | Q32 Bio Inc | $468.57M | 15.71 | - | - | |
OCGN | Ocugen Inc | $457.80M | - | +0.4% | - | |
PBYI | Puma Biotechnology Inc | $454.88M | 18.65 | -2.4% | - | |
LRMR | Larimar Therapeutics Inc | $445.14M | - | - | - | |
RZLT | Rezolute Inc | $442.94M | - | - | - | |
CABA | Cabaletta Bio Inc | $442.69M | - | - | - | |
EDIT | Editas Medicine Inc | $441.54M | - | +20.8% | - | |
PRLD | Prelude Therapeutics Inc | $431.68M | - | - | - |
Top Peer by Growth
Q32 Bio Inc
+81.9% YoY Revenue
Lowest P/E Ratio
Q32 Bio Inc
15.71x P/E
Best 1-Year Return
Q32 Bio Inc
+749.2% Return